Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 6U59 | B3UES2 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | |
| 6U59 | 6U59 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | |
| 6U59 | B3UEZ6 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | |
| 8TQ1 | Q2N0S6 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
| 8TQ1 | Q2N0S5 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
| 8TQ1 | 8TQ1 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
| 7PC2 | 7PC2 | HIV-1 Env (BG505 SOSIP.664) in complex with the IgA bNAb 7-269 and the antibody 3BNC117. | |
| 5WDU | Q2N0S8 | HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv | |
| 5WDU | 5WDU | HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv | |
| 5WDU | Q2N0S6 | HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv | |
| 8GPJ | 8GPJ | HIV-1 Env X16 UFO in complex with 8ANC195 Fab | |
| 8GPI | 8GPI | HIV-1 Env X18 UFO in complex with 8ANC195 Fab | |
| 8GPG | 8GPG | HIV-1 Env X18 UFO in complex with F6 Fab | |
| 8GJE | Q994M9 | HIV-1 Env subtype C CZA97.12 SOSIP.664 in complex with 3BNC117 Fab | |
| 8GJE | 8GJE | HIV-1 Env subtype C CZA97.12 SOSIP.664 in complex with 3BNC117 Fab | |
| 7T74 | 7T74 | HIV-1 Envelope ApexGT2 in complex with PCT64.35S Fab and RM20A3 Fab | |
| 7T75 | 7T75 | HIV-1 Envelope ApexGT2 in complex with RM20A3 Fab | |
| 7T73 | 7T73 | HIV-1 Envelope ApexGT2.2MUT in complex with PCT64.LMCA Fab | |
| 7T76 | 7T76 | HIV-1 Envelope ApexGT3 in complex with PG9.iGL Fab | |
| 7T77 | 7T77 | HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab | |
| 6X9R | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab | |
| 6X9R | 6X9R | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab | |
| 6X9T | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab | |
| 6X9T | 6X9T | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab | |
| 6X9S | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab | |
| 6X9S | 6X9S | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab | |
| 6X9V | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | |
| 6X9V | 6X9V | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | |
| 6X9U | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | |
| 6X9U | 6X9U | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | |
| 6MAR | Q2N0S6 | HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 | |
| 6MAR | Q2N0S7 | HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 | |
| 6MAR | 6MAR | HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 | |
| 1GC1 | P01730 | HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY | |
| 1GC1 | P04578 | HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY | |
| 1GC1 | 1GC1 | HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY | |
| 1G9M | P01730 | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | |
| 1G9M | P04578 | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | |
| 1G9M | 1G9M | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | |
| 1RZJ | P01730 | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | |
| 1RZJ | P04578 | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | |
| 1RZJ | 1RZJ | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B | |
| 3VQA | Q72498 | HIV-1 IN core domain in complex with 1-benzothiophen-6-amine 1,1-dioxide | |
| 3VQ7 | Q72498 | HIV-1 IN core domain in complex with 4-(1H-pyrrol-1-yl)aniline | |
| 2BGN | P27487 | HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) | |
| 2BGN | P56658 | HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) | |
| 2BGN | 2BGN | HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) | |
| 2BGN | P56658 | HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) | |
| 2BGN | 2BGN | HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) | |
| 2BGN | P12506 | HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) |
